Antibody molecules, or “immunoglobulins”, have been recognized only in vertebrates and all are found to have a fundamentally similar structure consisting of two heavy and two light peptide chains.

In little more than five years, German biotechnology company YUMAB (a phonetic play on HUMAB (human monoclonal antibody) in which the “Y” symbolizes the antibody structure) has become a global ...

U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer antibody company.” Both companies are focused on immunoglobulin ...

which are responsible for antibody synthesis, and cells with specific structures and functions, are the main components of the SSS microenvironment. The expression levels of immunoglobulin-related ...

Additionally, only a few of these antibodies specifically target the venom from the snake that caused the bite, requiring higher doses. Normally, cells take up antigens bound to immunoglobulin G (IgG) ...

The Food and Drug Administration (FDA) has approved Uplizna ® (inebilizumab-cdon) for the treatment of immunoglobulin G4-related disease ... a CD-19 directed cytolytic antibody, in 135 adults with ...

With an arsenal of antibody assets based on IgE, IgA, and IgG, the newly combined company has opportunities across cancer indications.